5 research outputs found
Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic Leukemia
The SLIT-ROBO axis plays an important role in normal stem-cell biology, with possible
repercussions on cancer stem cell emergence. Although the Promyelocytic Leukemia (PML) protein
can regulate SLIT2 expression in the central nervous system, little is known about SLIT2 in acute
promyelocytic leukemia. Hence, we aimed to investigate the levels of SLIT2 in acute promyelocytic
leukemia (APL) and assess its biological activity in vitro and in vivo. Our analysis indicated that
blasts with SLIT2high transcript levels were associated with cell cycle arrest, while SLIT2low APL
blasts displayed a more stem-cell like phenotype. In a retrospective analysis using a cohort of
patients treated with all-trans retinoic acid (ATRA) and anthracyclines, high SLIT2 expression was
correlated with reduced leukocyte count (p = 0.024), and independently associated with improved
overall survival (hazard ratio: 0.94; 95% confidence interval: 0.92–0.97; p < 0.001). Functionally,
SLIT2-knockdown in primary APL blasts and cell lines led to increased cell proliferation and resistance
to arsenic trioxide induced apoptosis. Finally, in vivo transplant of Slit2-silenced primary APL blasts
promoted increased leukocyte count (p = 0.001) and decreased overall survival (p = 0.002) compared
with the control. In summary, our data highlight the tumor suppressive function of SLIT2 in APL and
its deteriorating effects on disease progression when downregulated
High Δnp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia
The TP73 gene transcript is alternatively spliced and translated into the transcriptionally active (TAp73) or inactive (ΔNp73) isoforms, with opposite effects on the expression of p53 target genes and on apoptosis induction. The imbalance between ΔNp73 and TAp73 may contribute to tumorigenesis and resistance to chemotherapy in human cancers, including hematologic malignancies. In acute promyelocytic leukemia (APL), both isoforms are expressed, but their relevance in determining response to therapy and contribution to leukemogenesis remains unknown. Here, we provide the first evidence that a higher ΔNp73/TAp73 RNA expression ratio is associated with lower survival, lower disease-free survival, and higher risk of relapse in patients with APL homogeneously treated with all-trans retinoic acid and anthracycline-based chemotherapy, according to the International Consortium on Acute Promyelocytic Leukemia (IC-APL) study. Cox proportional hazards modeling showed that a high ΔNp73/TAp73 ratio was independently associated with shorter overall survival (hazard ratio, 4.47; 95% confidence interval, 1.64-12.2; P = .0035). Our data support the hypothesis that the ΔNp73/TAp73 ratio is an important determinant of clinical response in APL and may offer a therapeutic target for enhancing chemosensitivity in blast cells